A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity.

Michael V Mandola(Rowan University), Robert D. Ladner, Jan Stoehlmacher(University Hospital Carl Gustav Carus), Heinz‐Josef Lenz(University of Southern California), Gregory Cesarone, Susan Muller‐Weeks, Mimi C. Yu(State Administration of Traditional Chinese Medicine of the People's Republic of China)

PubMed

June 1, 2003

Cited by 363

Related Papers

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

|The Lancet Oncology|2017|2.8k

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

|The Lancet|2019|2.6k

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

|Journal of Clinical Oncology|2018|2.1k

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

|The Lancet Oncology|2009|960

Epidemiology of nasopharyngeal carcinoma

|Seminars in Cancer Biology|2002|941